MARC보기
LDR02153nam u200385 4500
001000000418946
00520190215163259
008181129s2015 |||||||||||||||||c||eng d
020 ▼a 9780438110496
035 ▼a (MiAaPQ)AAI10902388
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 247004
0820 ▼a 616
1001 ▼a Griggs, Ryan B.
24510 ▼a Targeting Methylglyoxal and PPAR Gamma to Alleviate Neuropathic Pain Associated with Type 2 Diabetes.
260 ▼a [S.l.]: ▼b University of Kentucky., ▼c 2015.
260 1 ▼a Ann Arbor: ▼b ProQuest Dissertations & Theses, ▼c 2015.
300 ▼a 269 p.
500 ▼a Source: Dissertation Abstracts International, Volume: 79-11(E), Section: B.
5021 ▼a Thesis (Ph.D.)--University of Kentucky, 2015.
520 ▼a Neuropathic pain affects up to 50% of the 29 million diabetic patients in the United States. Neuropathic pain in diabetes manifests as a disease of the peripheral and central nervous systems. The prevalence of type 2 diabetes is far greater than
520 ▼a I used methodological approaches including: (1) immunohistochemical and calcium imaging to assess stimulus-evoked sensitization
520 ▼a I hypothesized that the thiazolidinedione class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists would reduce neuropathic pain-like behavior and spinal neuron sensitization in traumatic nerve injury and type 2 diabetes. A
520 ▼a I aimed to investigate the contribution of the glucose metabolite methylglyoxal to painful type 2 diabetes. I tested the hypothesis that methylglyoxal produces nociceptive, evoked, and affective pain that is dependent on activation of the sensor
590 ▼a School code: 0102.
650 4 ▼a Neurosciences.
690 ▼a 0317
71020 ▼a University of Kentucky. ▼b Physiology.
7730 ▼t Dissertation Abstracts International ▼g 79-11B(E).
773 ▼t Dissertation Abstract International
790 ▼a 0102
791 ▼a Ph.D.
792 ▼a 2015
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T15000365 ▼n KERIS ▼z 이 자료의 원문은 한국교육학술정보원에서 제공합니다.
980 ▼a 201812 ▼f 2019
990 ▼a ***1012033